Navigation Links
AMRI Hires George Svokos as Senior Vice President Sales and General Manager - API
Date:1/10/2014

ALBANY, N.Y., Jan. 10, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) today announced the appointment of George Svokos, to the newly created position of Senior Vice President Sales and General Manager API, effective January 6, 2014. Mr. Svokos will report to William S. Marth, President and Chief Executive Officer.

"Mr. Svokos is a strategic thinker who comes to AMRI with years of experience in pharmaceutical manufacturing, business development, R&D, and sales and marketing," said Mr. Marth. "With his experience handling a large sales force in a multibillion dollar business, Mr. Svokos' main focus is to develop a commercial strategy around active pharmaceutical ingredients (APIs), as well as to assist on the sales side of the business."

Before coming to AMRI, Mr. Svokos had been with Teva Pharmaceuticals Industries Ltd. since 1979. Most recently, he was Senior Vice President of Product and Portfolio Selection, and Business Development, responsible for strategic planning, portfolio selection, new product introductions and business development. From 2011 to 2012, Mr. Svokos was Senior Vice President, US Technical Operations, responsible for strategic planning, manufacturing, supply chain, regulatory and legal compliance, and safety, for eleven U.S. dosage form manufacturing facilities, as well as supply of branded and generic products to the U.S. market from overseas plants in Europe, the Middle East, China and India. Before this role, he served as Executive Vice President of Commercial Operations, Teva API, leading the global sales and marketing of Teva's API division, including a global sales force, with multibillion-dollar sales. Mr. Svokos is the Senior Vice President of the Drug, Chemical & Associated Technologies Association (DCAT) and will become President next year.

Mr. Svokos earned a Master's degree in Business Administration from the University of Missouri and a Bachelor's of Science degree in Chemical Engineering from Columbia University.

About AMRI
Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development and manufacturing services. For over 22 years, AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers with informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development. For more information about AMRI, please visit our website at www.amriglobal.com or follow us on Twitter (@amriglobal).


'/>"/>
SOURCE Albany Molecular Research, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AMRI Hires Vijay Kumar Batra as Managing Director, AMRI India
2. FPR Specialty Pharmacy Hires Slomski To Lead Sales And Marketing; Moves To Next Phase In Cleveland Clinic Trials
3. inviCRO hires Stefan Linehan as Director of Ex Vivo Research & Imaging Services
4. Xcelience hires Clinical Supplies VP; Opens Birmingham, UK Site
5. Preventice hires Kevin Nickels as chief operating officer
6. Medolac Hires Doug Hawkins as Senior Executive
7. Spectrum Orthotics And Prosthetics Hires New Practitioner
8. SynGen Hires Former Pall Medical Executive as President of Cord Blood Business Unit
9. BioSante Hires VP of New Business Development and Contract Manufacturing and Announces New Appointment to Board of Directors
10. Tris Pharma Hires President for Generic Pharmaceuticals Business
11. United Medical Credit Hires More Staff to Contact Doctors and Promote their Financing Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... 9, 2016 Research and Markets has announced ... report to their offering. ... The global travel vaccines market to grow at a ... covers the present scenario and the growth prospects of the global ... report considers the revenue generated from the sales of various vaccines ...
(Date:12/8/2016)... , Dec. 8, 2016 Australia Ophthalmic Lasers ... report, "Australia Ophthalmic Lasers Market Outlook to 2022", provides ... The report provides value, in millions of US dollars, ... segements - Excimer Lasers, Femtosecond Lasers and YAG Lasers. ... shares data for each of these market segements, and ...
(Date:12/8/2016)... KEY FINDINGS The global medical ... Various reasons for growth of the medical lifting sling ... chronic diseases, high recovery cost of injuries and government ... lifting sling refers to an assistive device that helps ... connect to the lift and hold the patient. It ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... 08, 2016 , ... Russ DiGilio , founder and ... #QuackGivesBack campaign which supported local breast cancer organizations during National Breast Cancer Awareness ... Back initiative, and we’re very pleased with the participation in every franchisee’s ...
(Date:12/8/2016)... , ... December 08, 2016 , ... CURE Media Group, ... and advocacy groups, has aligned with Upstage Lung Cancer in efforts to combat lung ... announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored to team up ...
(Date:12/8/2016)... Fla (PRWEB) , ... December 08, 2016 , ... ... smarter modes of access for customers and employees that are both engaging and ... 7 with Service Smart Technology, the software company revealed today its plans to ...
(Date:12/8/2016)... ... 08, 2016 , ... STAT courier is pleased to announce that due to ... they are expanding their presence in Dallas. One of the most exciting parts for ... jobs to the Dallas and Forth Worth market. STAT takes pride in treating their ...
(Date:12/8/2016)... ... December 08, 2016 , ... Vida Health, the ... Series B led by Canvas Ventures . Other investors include Nokia Growth Partners ... mobile platform to serve more consumers who are managing chronic conditions or ...
Breaking Medicine News(10 mins):